Armed with new Phase I data, Icannex Healthcare is now focusing on a Phase II trial of its cannabidiol (CBD) and hydroxychloroquine combo therapy in rheumatoid arthritis.
KANSAS CITY, Mo., Sept. 12, 2022 /PRNewswire/ -- BioMed Valley Discoveries (BVD) announced that the first patient has been dosed in a phase II clinical trial of ulixertinib (BVD-523) in combination with hydroxychloroquine (HCQ). Ulixertinib is a first-in-class and best-in-class ERK inhibitor, with this clinical trial focusing on patients with advanced gastrointestinal malignancies and mutations in the MAPK pathway. This study builds upon the finding of the phase I study of the combination, which was completed at Huntsman Cancer Institute at the University of Utah.
TUCSON, Ariz., Jan. 17, 2022 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (AAPS) condemns the continued hoarding by the federal government of hydroxychloroquine, which it has kept in a stockpile while expensive new medications for Covid remain mostly unavailable.
Hydroxychloroquine, the anti-malaria drug controversially touted as a cure for COVID despite a lack of robust evidence, is creating renewed interest as a potential treatment for omicron.
Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception ncohort
Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception ncohort
HELENA, Mont. — One Montana hospital went into lockdown and called police after a woman threatened violence because her relative was denied her request to be treated with ivermectin.
CRANBURY, N.J., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a company focused on the growing field of cancer metabolism-based therapeutics, announced that the first patient has been enrolled in the APOLLO 613 Phase 1/2 clinical trial of CPI-613® (devimistat) in combination with hydroxychloroquine in patients with clear cell sarcoma at City of Hope in Duarte, California. Two additional sites have also been opened for enrollment in the trial at Cleveland Clinic Children’s and University of Michigan’s Rogel Cancer Center.
Paulo Rebello Filho, head of the National Regulatory Agency for Private Health Insurance Plans (ANS), said his staff has detected “assistance abnormalities” at Prevent Senior and the health chain will be put under special technical supervision.
Shipments containing Ivermectin tablets and Hydr